SEC Company Response from Generation Bio Co. (GBIO) (CIK 0001733294) — Jun 9, 2020
Generation Bio Co. (GBIO) (CIK 0001733294)
Date: June 9, 2020 · CIK: 0001733294 · Accession: 0001193125-20-164478
AI Filing Summary & Sentiment
File numbers found in text: 333-238608
Letter
Generation Bio Co.
301 Binney Street
Cambridge, MA
June 9, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C.
Attention: Courtney Lindsay
Re: Generation Bio Co.
Registration Statement on Form S-1
File No. 333-238608
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Generation Bio Co. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-238608), as amended, so that it may become effective at 4:00 p.m. Eastern time on June 11, 2020, or as soon thereafter as practicable, or at such later time as the Company or its counsel may orally request by telephone call to the staff of the U.S. Securities and Exchange Commission. Please contact Stuart M. Falber of Wilmer Cutler Pickering Hale and Dorr LLP, counsel to the Company, at (617) 526-6663, or in his absence, Molly W. Fox at (617) 526-6812, to provide notice of effectiveness, or if you have any other questions regarding this matter.
[Remainder of Page Intentionally Left Blank]
Very truly yours,
GENERATION BIO CO.
Show Raw Text
CORRESP 1 filename1.htm CORRESP Generation Bio Co. 301 Binney Street Cambridge, MA 02142 June 9, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Courtney Lindsay Re: Generation Bio Co. Registration Statement on Form S-1 File No. 333-238608 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Generation Bio Co. (the “Company”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-238608), as amended, so that it may become effective at 4:00 p.m. Eastern time on June 11, 2020, or as soon thereafter as practicable, or at such later time as the Company or its counsel may orally request by telephone call to the staff of the U.S. Securities and Exchange Commission. Please contact Stuart M. Falber of Wilmer Cutler Pickering Hale and Dorr LLP, counsel to the Company, at (617) 526-6663, or in his absence, Molly W. Fox at (617) 526-6812, to provide notice of effectiveness, or if you have any other questions regarding this matter. [Remainder of Page Intentionally Left Blank] Very truly yours, GENERATION BIO CO. By: /s/ Geoff McDonough Name: Geoff McDonough, M.D. Title: President and Chief Executive Officer